Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by LENZ Therapeutics, Inc.

LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics to Present at Upcoming Investor and Medical Conferences
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of Presbyopia
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics to Present at Upcoming Investor Conferences
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics to Host Commercial Day on April 15, 2025
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics to Participate in Upcoming Investor Conferences
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics to Participate in Upcoming Investor Conferences
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics Reports Third Quarter 2024 Financial Results
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics Announces Presentations at Upcoming Ophthalmology and Optometry Medical Conferences
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics to Participate in Upcoming Investor Conferences
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics Reports Second Quarter 2024 Financial Results
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics Announces $30 Million Investment from Ridgeback Capital
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.